|
|||||
|
|
Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China |
|
| Authors: | Wenfeng Fang Shen Zhao Yaxiong Zhang Yuxiang Ma Hongyun Zhao Li Zhang |
| Affiliation: | 1. Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China Contributed equally.;2. Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China Contributed equally.;3. Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China;4. Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China |
| Abstract: | |
| Keywords: | Phase I studies Immune checkpoint inhibitors Pharmacokinetics Pharmacodynamics China |